English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Tuesday, February 18, 2020
AIM ImmunoTech Issues Stockholder Update on the Potential Role of Ampligen for Use Against the Wuhan Coronavirus Epidemic
AIM ImmunoTech Issues Stockholder Update on the Potential Role of Ampligen for Use Against the Coronavirus Epidemic
Tuesday, February 11, 2020
AIM ImmunoTech Files Three Provisional Patent Applications Surrounding Ampligen(R) for Use Against the SARS-like Wuhan 2019 Novel Coronavirus
AIM ImmunoTech提交了三项有关安普利近(R) 的临时专利申请,以用于对抗类似SARS的武汉2019年新型冠状病毒
AIM ImmunoTech提交了三項有關安普利近(R) 的臨時專利申請,以用於對抗類似SARS的武漢2019年新型冠狀病毒

Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575